NDAORALSYRUP
Approved
Nov 1960
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
DECLOMYCIN (demeclocycline hydrochloride) by Pfizer is clinical pharmacology pharmacokinetics the absorption of demeclocycline is slower than that of tetracycline. Approved for infections caused by the following gram-negative microorganisms, bacteriologic testing indicates appropriate susceptibility to the drug: escherichia coli, infections caused by the following gram-positive microorganisms and 7 more indications. First approved in 1960.
Drug data last refreshed 20h ago
Mechanism of Action
CLINICAL PHARMACOLOGY Pharmacokinetics The absorption of demeclocycline is slower than that of tetracycline. The time to reach the peak concentration is about 4 hours. After a 150 mg oral dose of demeclocycline tablet, the mean concentrations at 1 hour and 3 hours are 0.46 and 1.22 mcg/mL (n = 6),…
Worked on DECLOMYCIN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.